{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:07:05Z","timestamp":1794604025520,"version":"4.9.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Psoriasis represents a chronic autoimmune skin condition defined by various clinical forms, including inverse, erythrodermic, pustular, guttate, plaque types. While current therapies, including topical treatments but also systemic through conventional synthetic drugs and biologics, have improved symptom management, no treatment completely cures the disease, and numerous options are linked to considerable adverse effects, including immunosuppression and carcinogenic risks. Therefore, there is growing interest in bioactive compounds from natural sources due to their potential to reduce inflammation and oxidative stress in psoriasis with fewer adverse effects. The present narrative review aimed to address the limitations of current psoriasis therapies by exploring the therapeutic potential of bioactive compounds in the classes of flavonoids, terpenoids, omega-3 fatty acids, and alkaloids assessed through complex experimental models, focusing on their immunomodulatory and anti-inflammatory properties. Recent studies highlight the efficacy of natural bioactive compounds in reducing psoriasis symptoms, either as standalone treatments or in combination with conventional therapies. While these compounds show promise in alleviating psoriasis-related inflammation, further research is needed to optimize their therapeutic use, understand their mechanisms of action, and assess long-term safety. Future studies should focus on clinical trials to establish standardized protocols for incorporating bioactive compounds into psoriasis management and explore their potential role in personalized treatment strategies. Continued research is essential to develop more effective, safer, and affordable therapeutic options for psoriasis patients.<\/jats:p>","DOI":"10.1007\/s10787-024-01602-z","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:17:19Z","timestamp":1732277839000},"page":"527-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7625-8177","authenticated-orcid":false,"given":"Ada","family":"Radu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Maria","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei-Flavius","family":"Radu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmin Mihai","family":"Vesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Gabriela","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"1602_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.jid.5700510","volume":"127","author":"F Afaq","year":"2007","unstructured":"Afaq F, Syed DN, Malik A et al (2007) Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. J Investig Dermatol 127:222\u2013232","journal-title":"J Investig Dermatol"},{"key":"1602_CR2","doi-asserted-by":"crossref","unstructured":"Aghmiuni AI, Khiavi AA, Aghmiuni AI, Khiavi AA (2017) Medicinal plants to calm and treat psoriasis disease. IntechOpen","DOI":"10.5772\/67062"},{"key":"1602_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119256","volume":"581","author":"A Alalaiwe","year":"2020","unstructured":"Alalaiwe A, Lin C-F, Hsiao C-Y et al (2020) Development of flavanone and its derivatives as topical agents against psoriasis: the prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay. Int J Pharm 581:119256","journal-title":"Int J Pharm"},{"key":"1602_CR4","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.2340\/actadv.v103.6525","volume":"103","author":"D Amiri","year":"2023","unstructured":"Amiri D, Schwarz CW, Gether L, Skov L (2023) Safety and efficacy of topical calcineurin inhibitors in the treatment of facial and genital psoriasis: a systematic review. Acta Derm Venereol 103:6525","journal-title":"Acta Derm Venereol"},{"key":"1602_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11010-015-2641-6","volume":"413","author":"J An","year":"2016","unstructured":"An J, Li Z, Dong Y et al (2016) Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-\u03baB-mediated inflammation and keratinocyte proliferation. Mol Cell Biochem 413:87\u201395","journal-title":"Mol Cell Biochem"},{"key":"1602_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW et al (2021) Psoriasis prevalence in adults in the United States. JAMA Dermatol 157:940\u2013946","journal-title":"JAMA Dermatol"},{"key":"1602_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.bbrc.2013.12.128","volume":"443","author":"HR Austin","year":"2014","unstructured":"Austin HR, Hoss E, Batie SF et al (2014) Regulation of late cornified envelope genes relevant to psoriasis risk by plant-derived cyanidin. Biochem Biophys Res Commun 443:1275\u20131279","journal-title":"Biochem Biophys Res Commun"},{"key":"1602_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/1389202923666220527111037","volume":"23","author":"F Babaie","year":"2022","unstructured":"Babaie F, Omraninava M, Gorabi AM et al (2022) Etiopathogenesis of psoriasis from genetic perspective: an updated review. Curr Genom 23:163\u2013174","journal-title":"Curr Genom"},{"key":"1602_CR9","first-page":"560","volume":"19","author":"T Badri","year":"2023","unstructured":"Badri T, Kumar P, Oakley AM (2023) Plaque psoriasis. Pract Nurs 19:560\u2013565","journal-title":"Pract Nurs"},{"key":"1602_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1574886315666200128095958","volume":"15","author":"H Bakshi","year":"2020","unstructured":"Bakshi H, Nagpal M, Singh M et al (2020) Treatment of psoriasis: a comprehensive review of entire therapies. Curr Drug Saf 15:82\u2013104","journal-title":"Curr Drug Saf"},{"key":"1602_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/CCID.S17220","volume":"4","author":"GM Balb\u00e1s","year":"2011","unstructured":"Balb\u00e1s GM, Rega\u00f1a MS, Millet PU (2011) Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol 4:73\u201377","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1602_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12967-014-0372-1","volume":"13","author":"L Barrea","year":"2015","unstructured":"Barrea L, Balato N, Di Somma C et al (2015) Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med 13:18","journal-title":"J Transl Med"},{"key":"1602_CR13","first-page":"247","volume":"15","author":"F Bellinato","year":"2021","unstructured":"Bellinato F, Gisondi P, Girolomoni G (2021) Latest advances for the treatment of chronic plaque psoriasis with biologics and oral small molecules. Biologics 15:247\u2013253","journal-title":"Biologics"},{"key":"1602_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.micinf.2019.06.009","volume":"21","author":"E Bianchi","year":"2019","unstructured":"Bianchi E, Rogge L (2019) The IL-23\/IL-17 pathway in human chronic inflammatory diseases\u2014new insight from genetics and targeted therapies. Microbes Infect 21:246\u2013253","journal-title":"Microbes Infect"},{"key":"1602_CR15","first-page":"39","volume":"15","author":"ND Brownstone","year":"2021","unstructured":"Brownstone ND, Hong J, Mosca M et al (2021) Biologic treatments of psoriasis: an update for the clinician. Biologics 15:39\u201351","journal-title":"Biologics"},{"key":"1602_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5070\/D30W66C5GG","volume":"9","author":"CR Bruner","year":"2003","unstructured":"Bruner CR, Feldman SR, Ventrapragada M, Fleischer ABJ (2003) A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J 9:2","journal-title":"Dermatol Online J"},{"key":"1602_CR17","first-page":"3","volume":"24","author":"SG Bungau","year":"2015","unstructured":"Bungau SG, Popa VC (2015) Between religion and science: some aspects: concerning illness and healing in antiquity. Transylv Rev 24:3\u201319","journal-title":"Transylv Rev"},{"key":"1602_CR18","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/biomedicines9111511","volume":"9","author":"A Campanati","year":"2021","unstructured":"Campanati A, Marani A, Martina E et al (2021) Psoriasis as an immune-mediated and inflammatory systemic disease: from pathophysiology to novel therapeutic approaches. Biomedicines 9:1511","journal-title":"Biomedicines"},{"key":"1602_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/pharmaceutics16020239","volume":"16","author":"E Carmona-Rocha","year":"2024","unstructured":"Carmona-Rocha E, Rusi\u00f1ol L, Puig L (2024) New and emerging oral\/topical small-molecule treatments for psoriasis. Pharmaceutics 16:239","journal-title":"Pharmaceutics"},{"key":"1602_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/exd.12140","volume":"22","author":"JC Chamcheu","year":"2013","unstructured":"Chamcheu JC, Afaq F, Syed DN et al (2013) Delphinidin, a dietary antioxidant, induces human epidermal keratinocyte differentiation but not apoptosis: studies in submerged and three-dimensional epidermal equivalent models. Exp Dermatol 22:342\u2013348","journal-title":"Exp Dermatol"},{"key":"1602_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000368445","volume":"28","author":"JC Chamcheu","year":"2015","unstructured":"Chamcheu JC, Pal HC, Siddiqui IA et al (2015) Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis. Skin Pharmacol Physiol 28:177\u2013188","journal-title":"Skin Pharmacol Physiol"},{"key":"1602_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1345\/aph.19029","volume":"35","author":"TY Chan","year":"2001","unstructured":"Chan TY (2001) Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 35:501\u2013504","journal-title":"Ann Pharmacother"},{"key":"1602_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eujim.2014.12.006","volume":"7","author":"K Chan","year":"2015","unstructured":"Chan K, Hu X-Y, Razmovski-Naumovski V, Robinson N (2015) Challenges and opportunities of integrating traditional Chinese medicine into mainstream medicine: a review of the current situation. Eur J Integr Med 7:67\u201375","journal-title":"Eur J Integr Med"},{"key":"1602_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","volume":"48","author":"H Chen","year":"2017","unstructured":"Chen H, Lu C, Liu H et al (2017a) Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway. Int Immunopharmacol 48:110\u2013117","journal-title":"Int Immunopharmacol"},{"key":"1602_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.020","volume":"271","author":"Q Chen","year":"2017","unstructured":"Chen Q, Zhou H, Yang Y et al (2017b) Investigating the potential of Oxymatrine as a psoriasis therapy. Chem Biol Interact 271:59\u201366","journal-title":"Chem Biol Interact"},{"key":"1602_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jff.2017.08.034","volume":"38","author":"S Chen","year":"2017","unstructured":"Chen S, Li H, Liu Y et al (2017c) Quercitrin extracted from Tartary buckwheat alleviates imiquimod-induced psoriasis-like dermatitis in mice by inhibiting the Th17 cell response. J Funct Foods 38:9\u201319","journal-title":"J Funct Foods"},{"key":"1602_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/nutrit\/nuz098","volume":"78","author":"X Chen","year":"2020","unstructured":"Chen X, Hong S, Sun X et al (2020) Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials. Nutr Rev 78:827\u2013840","journal-title":"Nutr Rev"},{"key":"1602_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10067-019-04456-x","volume":"38","author":"CCT Clark","year":"2019","unstructured":"Clark CCT, Taghizadeh M, Nahavandi M, Jafarnejad S (2019) Efficacy of \u03c9-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin Rheumatol 38:977\u2013988","journal-title":"Clin Rheumatol"},{"key":"1602_CR29","unstructured":"ClinicalTrials.gov. (2024) National Library of Medicine. https:\/\/clinicaltrials.gov\/. Accessed 8 Oct 2024"},{"key":"1602_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/805705","volume":"2013","author":"MD Colombo","year":"2013","unstructured":"Colombo MD, Cassano N, Bellia G, Vena GA (2013) Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches. Sci World J 2013:805705","journal-title":"Sci World J"},{"key":"1602_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/pdia.2014.47121","volume":"31","author":"M Czarnecka-Operacz","year":"2014","unstructured":"Czarnecka-Operacz M, Sadowska-Przytocka A (2014) The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge. Postep Dermatol Alergol 31:392\u2013400","journal-title":"Postep Dermatol Alergol"},{"key":"1602_CR32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/ptr.6973","volume":"35","author":"N Dabholkar","year":"2021","unstructured":"Dabholkar N, Rapalli VK, Singhvi G (2021) Potential herbal constituents for psoriasis treatment as protective and effective therapy. Phytother Res 35:2429\u20132444","journal-title":"Phytother Res"},{"key":"1602_CR33","first-page":"182","volume":"29","author":"A Danczak-Pazdrowska","year":"2012","unstructured":"Danczak-Pazdrowska A (2012) Place of methotrexate in the treatment of psoriasis in the era of biologic agents. Postep Dermatol Alergol 29:182\u2013188","journal-title":"Postep Dermatol Alergol"},{"key":"1602_CR34","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1093\/hmg\/ddx328","volume":"26","author":"N Dand","year":"2017","unstructured":"Dand N, Mucha S, Tsoi LC et al (2017) Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Hum Mol Genet 26:4301\u20134313","journal-title":"Hum Mol Genet"},{"key":"1602_CR35","doi-asserted-by":"publisher","first-page":"adv00030","DOI":"10.2340\/00015555-3384","volume":"100","author":"N Dand","year":"2020","unstructured":"Dand N, Mahil SK, Capon F et al (2020) Psoriasis and Genetics. Acta Derm Venereol 100:adv00030","journal-title":"Acta Derm Venereol"},{"key":"1602_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","volume":"32","author":"T-T Di","year":"2016","unstructured":"Di T-T, Ruan Z-T, Zhao J-X et al (2016) Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway. Int Immunopharmacol 32:32\u201338","journal-title":"Int Immunopharmacol"},{"key":"1602_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/ced.12062","volume":"38","author":"S Dogra","year":"2013","unstructured":"Dogra S, Mahajan R (2013) Systemic methotrexate therapy for psoriasis: past, present and future. Clin Exp Dermatol 38:573\u2013588","journal-title":"Clin Exp Dermatol"},{"key":"1602_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fphar.2013.00177","volume":"4","author":"M Ekor","year":"2014","unstructured":"Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177","journal-title":"Front Pharmacol"},{"key":"1602_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF et al (2021) Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol 84:432\u2013470","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR40","unstructured":"FDA Novel Drug Therapy Approvals for 2022 (2024) https:\/\/www.fda.gov\/drugs\/novel-drug-approvals-fda\/novel-drug-approvals-2022. Accessed 5 Oct 2024"},{"key":"1602_CR41","unstructured":"FDA Novel Drug Therapy Approvals for 2023 (2024) https:\/\/www.fda.gov\/drugs\/novel-drug-approvals-fda\/novel-drug-approvals-2023. Accessed 5 Oct 2024"},{"key":"1602_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/nu14010119","volume":"14","author":"J Garbicz","year":"2021","unstructured":"Garbicz J, Ca\u0142yniuk B, G\u00f3rski M et al (2021) Nutritional therapy in persons suffering from psoriasis. Nutrients 14:119","journal-title":"Nutrients"},{"key":"1602_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2024.100387","volume":"10","author":"R Gaur","year":"2024","unstructured":"Gaur R (2024) A brief history: traditional Chinese medicinal system. Pharmacol Res Mod Chin Med 10:100387","journal-title":"Pharmacol Res Mod Chin Med"},{"key":"1602_CR44","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3945\/ajcn.2008.26427","volume":"88","author":"P Gisondi","year":"2008","unstructured":"Gisondi P, Del Giglio M, Di Francesco V et al (2008) Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 88:1242\u20131247","journal-title":"Am J Clin Nutr"},{"key":"1602_CR45","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","volume":"183","author":"WA Goodman","year":"2009","unstructured":"Goodman WA, Levine AD, Massari JV et al (2009) IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183:3170\u20133176","journal-title":"J Immunol"},{"key":"1602_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.det.2024.02.006","volume":"42","author":"JE Hawkes","year":"2024","unstructured":"Hawkes JE, Al-Saedy M, Bouch\u00e9 N et al (2024) The psoriasis treatment pipeline: an overview and update. Dermatol Clin 42:365\u2013375","journal-title":"Dermatol Clin"},{"key":"1602_CR47","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1055\/s-0042-115177","volume":"82","author":"A Herman","year":"2016","unstructured":"Herman A, Herman AP (2016) Topically used herbal products for the treatment of psoriasis\u2014mechanism of action, drug delivery, clinical studies. Planta Med 82:1447\u20131455","journal-title":"Planta Med"},{"key":"1602_CR48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/exd.13024","volume":"25","author":"K-F Huang","year":"2016","unstructured":"Huang K-F, Ma K-H, Liu P-S et al (2016) Baicalein increases keratin 1 and 10 expression in HaCaT keratinocytes via TRPV4 receptor activation. Exp Dermatol 25:623\u2013629","journal-title":"Exp Dermatol"},{"key":"1602_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105817","volume":"75","author":"Z-Z Huang","year":"2019","unstructured":"Huang Z-Z, Xu Y, Xu M et al (2019) Artesunate alleviates imiquimod-induced psoriasis-like dermatitis in BALB\/c mice. Int Immunopharmacol 75:105817","journal-title":"Int Immunopharmacol"},{"key":"1602_CR50","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1055\/a-0622-8242","volume":"84","author":"C-H Hung","year":"2018","unstructured":"Hung C-H, Wang C-N, Cheng H-H et al (2018) Baicalin ameliorates imiquimod-induced psoriasis-like inflammation in mice. Planta Med 84:1110\u20131117","journal-title":"Planta Med"},{"key":"1602_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/1744666X.2021.1886081","volume":"17","author":"H Iznardo","year":"2021","unstructured":"Iznardo H, Puig L (2021) The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives. Expert Rev Clin Immunol 17:187\u2013199","journal-title":"Expert Rev Clin Immunol"},{"key":"1602_CR52","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2165\/00003495-200161150-00002","volume":"61","author":"AA Izzo","year":"2001","unstructured":"Izzo AA, Ernst E (2001) Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61:2163\u20132175","journal-title":"Drugs"},{"key":"1602_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.81","volume":"49","author":"Y-J Jeon","year":"2017","unstructured":"Jeon Y-J, Sah SK, Yang HS et al (2017) Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice. Exp Mol Med 49:e349","journal-title":"Exp Mol Med"},{"key":"1602_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.taap.2009.12.005","volume":"243","author":"SA Jordan","year":"2010","unstructured":"Jordan SA, Cunningham DG, Marles RJ (2010) Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 243:198\u2013216","journal-title":"Toxicol Appl Pharmacol"},{"key":"1602_CR55","first-page":"157","volume":"10","author":"P Katsimbri","year":"2021","unstructured":"Katsimbri P, Korakas E, Kountouri A et al (2021) The effect of antioxidant and anti-inflammatory capacity of diet on psoriasis and psoriatic arthritis phenotype: nutrition as therapeutic tool? Antioxidants (Basel, Switzerland) 10:157","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"1602_CR56","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/1472-6882-13-336","volume":"13","author":"JH Kim","year":"2013","unstructured":"Kim JH, Kwong EMS, Chung VCH et al (2013) Acute adverse events from over-the-counter Chinese herbal medicines: a population-based survey of Hong Kong Chinese. BMC Complement Altern Med 13:336","journal-title":"BMC Complement Altern Med"},{"key":"1602_CR57","first-page":"278","volume":"63","author":"WB Kim","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J (2017) Diagnosis and management of psoriasis. Can Fam Physician 63:278\u2013285","journal-title":"Can Fam Physician"},{"key":"1602_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106767","volume":"87","author":"N Kim","year":"2020","unstructured":"Kim N, Lee S, Kang J et al (2020) Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1\/Th17 cell population and keratinocyte activation. Int Immunopharmacol 87:106767","journal-title":"Int Immunopharmacol"},{"key":"1602_CR59","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jaad.2007.12.035","volume":"58","author":"SK Kurd","year":"2008","unstructured":"Kurd SK, Smith N, VanVoorhees A et al (2008) Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol 58:625\u2013631","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR60","doi-asserted-by":"publisher","first-page":"3908061","DOI":"10.1155\/2017\/3908061","volume":"2017","author":"T Kuwabara","year":"2017","unstructured":"Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T (2017) The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm 2017:3908061","journal-title":"Mediators Inflamm"},{"key":"1602_CR61","first-page":"751","volume":"8","author":"CS Lee","year":"2009","unstructured":"Lee CS, Koo J (2009) The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison. J Drugs Dermatol 8:751\u2013755","journal-title":"J Drugs Dermatol"},{"key":"1602_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116924","volume":"318","author":"C-L Lee","year":"2024","unstructured":"Lee C-L, Wang C-M, Song Y-C et al (2024) An alkaloid-rich phytopharmaceutical prepared from Qing Dai against IL-17A-induced psoriasis. J Ethnopharmacol 318:116924","journal-title":"J Ethnopharmacol"},{"key":"1602_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.intimp.2018.04.018","volume":"59","author":"P Li","year":"2018","unstructured":"Li P, Li Y, Jiang H et al (2018) Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB\/c mice. Int Immunopharmacol 59:243\u2013251","journal-title":"Int Immunopharmacol"},{"key":"1602_CR64","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lfs.2019.01.019","volume":"219","author":"X Li","year":"2019","unstructured":"Li X, Xie X, Zhang L et al (2019) Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1\/ERK1\/2 pathway. Life Sci 219:311\u2013321","journal-title":"Life Sci"},{"key":"1602_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cei.13363","volume":"198","author":"C Liu","year":"2019","unstructured":"Liu C, Liu H, Lu C et al (2019) Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin Exp Immunol 198:403\u2013415","journal-title":"Clin Exp Immunol"},{"key":"1602_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/PTT.S288345","volume":"11","author":"Y Lo","year":"2021","unstructured":"Lo Y, Tsai T-F (2021) Updates on the treatment of erythrodermic psoriasis. Psoriasis 11:59\u201373","journal-title":"Psoriasis"},{"key":"1602_CR67","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2133.2000.04713.x","volume":"146","author":"J Mason","year":"2002","unstructured":"Mason J, Mason AR, Cork MJ (2002) Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 146:351\u2013364","journal-title":"Br J Dermatol"},{"key":"1602_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0021-9150(03)00015-7","volume":"167","author":"C Meisel","year":"2003","unstructured":"Meisel C, Johne A, Roots I (2003) Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 167:367","journal-title":"Atherosclerosis"},{"key":"1602_CR69","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA et al (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 60:643\u2013659","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR70","first-page":"92","volume":"12","author":"A Menter","year":"2013","unstructured":"Menter A, Gold LS, Bukhalo M et al (2013) Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. J Drugs Dermatol 12:92\u201398","journal-title":"J Drugs Dermatol"},{"key":"1602_CR71","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","volume":"80","author":"A Menter","year":"2019","unstructured":"Menter A, Strober BE, Kaplan DH et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 80:1029\u20131072","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR72","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaad.2020.02.044","volume":"82","author":"A Menter","year":"2020","unstructured":"Menter A, Gelfand JM, Connor C et al (2020) Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol 82:1445\u20131486","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR73","first-page":"1","volume":"96","author":"S Menting","year":"2015","unstructured":"Menting S, Dekker P, Limpens J et al (2015) Methotrexate dosing regimen for plaque-type psoriasis: a systematic review of the use of test-dose, start-dose, dosing scheme, dose adjustments, maximum dose and folic acid supplementation. Acta Derm Venereol 96:1\u201313","journal-title":"Acta Derm Venereol"},{"key":"1602_CR74","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/CCID.S189000","volume":"12","author":"G Micali","year":"2019","unstructured":"Micali G, Verz\u00ec AE, Giuffrida G et al (2019) Inverse psoriasis: from diagnosis to current treatment options. Clin Cosmet Investig Dermatol 12:953\u2013959","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1602_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/ITT.S240891","volume":"10","author":"M Mosca","year":"2021","unstructured":"Mosca M, Hong J, Hadeler E et al (2021) The role of IL-17 cytokines in psoriasis. ImmunoTargets Ther 10:409\u2013418","journal-title":"ImmunoTargets Ther"},{"key":"1602_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15685","volume":"35","author":"ML Musumeci","year":"2022","unstructured":"Musumeci ML, Nasca MR, Boscaglia S, Micali G (2022) The role of lifestyle and nutrition in psoriasis: current status of knowledge and interventions. Dermatol Ther 35:e15685","journal-title":"Dermatol Ther"},{"key":"1602_CR77","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00403-017-1748-x","volume":"309","author":"H My\u015bliwiec","year":"2017","unstructured":"My\u015bliwiec H, Baran A, Harasim-Symbor E et al (2017) Serum fatty acid profile in psoriasis and its comorbidity. Arch Dermatol Res 309:371\u2013380","journal-title":"Arch Dermatol Res"},{"key":"1602_CR78","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199\u2013204","journal-title":"Nat Genet"},{"key":"1602_CR79","unstructured":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024) Types of psoriasis. https:\/\/www.niams.nih.gov\/health-topics\/psoriasis. Accessed 1 Oct 2024"},{"key":"1602_CR80","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/molecules27030591","volume":"27","author":"M Nowak-Perlak","year":"2022","unstructured":"Nowak-Perlak M, Szpadel K, Jab\u0142o\u0144ska I et al (2022) Promising strategies in plant-derived treatments of psoriasis-update of in vitro, in vivo, and clinical trials studies. Molecules 27:591","journal-title":"Molecules"},{"key":"1602_CR81","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1358\/dot.2010.46.5.1473264","volume":"46","author":"JL O\u2019Neill","year":"2010","unstructured":"O\u2019Neill JL, Feldman SR (2010) Vitamine D analogue-based therapies for psoriasis. Drugs Today 46:351\u2013360","journal-title":"Drugs Today"},{"key":"1602_CR82","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2131\/jts.35.653","volume":"35","author":"M Ohbayashi","year":"2010","unstructured":"Ohbayashi M, Suzuki M, Yashiro Y et al (2010) Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J Toxicol Sci 35:653\u2013661","journal-title":"J Toxicol Sci"},{"key":"1602_CR83","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","volume":"129","author":"RM Onishi","year":"2010","unstructured":"Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129:311\u2013321","journal-title":"Immunology"},{"key":"1602_CR84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/vaccines8030517","volume":"8","author":"B Pahar","year":"2020","unstructured":"Pahar B, Madonna S, Das A et al (2020) Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections. Vaccines 8:517","journal-title":"Vaccines"},{"key":"1602_CR85","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/bjd.13513","volume":"172","author":"HC Pal","year":"2015","unstructured":"Pal HC, Chamcheu JC, Adhami VM et al (2015) Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation. Br J Dermatol 172:354\u2013364","journal-title":"Br J Dermatol"},{"key":"1602_CR86","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/135206","volume":"2012","author":"B Polj\u0161ak","year":"2012","unstructured":"Polj\u0161ak B, Dahmane R (2012) Free radicals and extrinsic skin aging. Dermatol Res Pract 2012:135206. https:\/\/doi.org\/10.1155\/2012\/135206","journal-title":"Dermatol Res Pract"},{"key":"1602_CR87","unstructured":"PubChem (2024) National Library of Medicine. National Center for Biotechnology Information. https:\/\/pubchem.ncbi.nlm.nih.gov\/. Accessed 29 Oct 2024"},{"key":"1602_CR88","first-page":"457","volume":"46","author":"D Puri","year":"2002","unstructured":"Puri D, Prabhu KM, Murthy PS (2002) Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol 46:457\u2013462","journal-title":"Indian J Physiol Pharmacol"},{"key":"1602_CR89","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN (2021) Psoriasis: a brief overview. Clin Med (Northfield Il) 21:170\u2013173","journal-title":"Clin Med (Northfield Il)"},{"key":"1602_CR90","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/gels9120973","volume":"9","author":"K Reena","year":"2023","unstructured":"Reena K, Mittal S, Faizan M et al (2023) Enhancement of curcumin\u2019s anti-psoriatic efficacy via formulation into tea tree oil-based emulgel. Gels 9:973","journal-title":"Gels"},{"issue":"Suppl 2","key":"1602_CR91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","volume":"26","author":"K Reich","year":"2012","unstructured":"Reich K (2012) The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol 26(Suppl 2):3\u201311","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1602_CR92","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s13555-022-00881-0","volume":"13","author":"R Rivera-D\u00edaz","year":"2023","unstructured":"Rivera-D\u00edaz R, Daud\u00e9n E, Carrascosa JM et al (2023) Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment. Dermatol Ther (Heidelb) 13:673\u2013688","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1602_CR93","first-page":"79","volume":"3","author":"G Sarac","year":"2016","unstructured":"Sarac G, Koca TT, Baglan T (2016) A brief summary of clinical types of psoriasis. N Clin Istanbul 3:79\u201382","journal-title":"N Clin Istanbul"},{"key":"1602_CR94","doi-asserted-by":"publisher","first-page":"256","DOI":"10.5114\/pdia.2014.40954","volume":"31","author":"AG Shabgah","year":"2014","unstructured":"Shabgah AG, Fattahi E, Shahneh FZ (2014) Interleukin-17 in human inflammatory diseases. Postep Dermatol Alergol 31:256\u2013261","journal-title":"Postep Dermatol Alergol"},{"key":"1602_CR95","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaad.2021.02.057","volume":"85","author":"NH Shear","year":"2021","unstructured":"Shear NH, Betts KA, Soliman AM et al (2021) Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: a network meta-analysis of clinical trial data. J Am Acad Dermatol 85:572\u2013581","journal-title":"J Am Acad Dermatol"},{"key":"1602_CR96","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/0019-5154.62754","volume":"55","author":"RK Sivamani","year":"2010","unstructured":"Sivamani RK, Correa G, Ono Y et al (2010) Biological therapy of psoriasis. Indian J Dermatol 55:161\u2013170","journal-title":"Indian J Dermatol"},{"key":"1602_CR97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0891-5849(00)00304-X","volume":"29","author":"CF Skibola","year":"2000","unstructured":"Skibola CF, Smith MT (2000) Potential health impacts of excessive flavonoid intake. Free Radic Biol Med 29:375\u2013383","journal-title":"Free Radic Biol Med"},{"key":"1602_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192297","volume":"13","author":"E Smoli\u0144ska","year":"2018","unstructured":"Smoli\u0144ska E, Moskot M, Jak\u00f3bkiewicz-Banecka J et al (2018) Molecular action of isoflavone genistein in the human epithelial cell line HaCaT. PLoS\u00a0One 13:e0192297","journal-title":"PLoS\u00a0One"},{"key":"1602_CR99","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cosmetics5010013","volume":"5","author":"ML Soto","year":"2018","unstructured":"Soto ML, Parada M, Falqu\u00e9 E, Dom\u00ednguez H (2018) Personal-care products formulated with natural antioxidant extracts. Cosmetics 5:13. https:\/\/doi.org\/10.3390\/cosmetics5010013","journal-title":"Cosmetics"},{"key":"1602_CR100","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","volume":"9","author":"RS Stern","year":"2004","unstructured":"Stern RS, Nijsten T, Feldman SR et al (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136\u2013139","journal-title":"J Investig Dermatol Symp Proc"},{"key":"1602_CR101","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","author":"A Strange","year":"2010","unstructured":"Strange A, Capon F, Spencer CCA et al (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985\u2013990","journal-title":"Nat Genet"},{"key":"1602_CR102","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41419-019-1510-8","volume":"10","author":"S Sun","year":"2019","unstructured":"Sun S, Zhang X, Xu M et al (2019) Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes. Cell Death Dis 10:274","journal-title":"Cell Death Dis"},{"key":"1602_CR103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng.2827","volume":"46","author":"H Tang","year":"2014","unstructured":"Tang H, Jin X, Li Y et al (2014) A large-scale screen for coding variants predisposing to psoriasis. Nat Genet 46:45\u201350","journal-title":"Nat Genet"},{"key":"1602_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108307","volume":"689","author":"K Toda","year":"2020","unstructured":"Toda K, Tsukayama I, Nagasaki Y et al (2020) Red-kerneled rice proanthocyanidin inhibits arachidonate 5-lipoxygenase and decreases psoriasis-like skin inflammation. Arch Biochem Biophys 689:108307","journal-title":"Arch Biochem Biophys"},{"key":"1602_CR105","unstructured":"Traditional Chinese Medicine Needs Proper Scrutiny (2024) In: Nature. https:\/\/www.nature.com\/articles\/d41586-017-07650-6. Accessed 29 Oct 2024"},{"key":"1602_CR106","doi-asserted-by":"publisher","first-page":"17517","DOI":"10.3390\/ijms242417517","volume":"24","author":"D Turcov","year":"2023","unstructured":"Turcov D, Zbranca-Toporas A, Suteu D (2023) Bioactive compounds for combating oxidative stress in dermatology. Int J Mol Sci 24:17517","journal-title":"Int J Mol Sci"},{"key":"1602_CR107","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.3390\/ijms222111574","volume":"22","author":"M Vi\u010di\u0107","year":"2021","unstructured":"Vi\u010di\u0107 M, Ka\u0161telan M, Brajac I et al (2021) Current concepts of psoriasis immunopathogenesis. Int J Mol Sci 22:11574","journal-title":"Int J Mol Sci"},{"key":"1602_CR108","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.intimp.2019.01.054","volume":"69","author":"A Wang","year":"2019","unstructured":"Wang A, Wei J, Lu C et al (2019) Genistein suppresses psoriasis-related inflammation through a STAT3-NF-\u03baB-dependent mechanism in keratinocytes. Int Immunopharmacol 69:270\u2013278","journal-title":"Int Immunopharmacol"},{"key":"1602_CR109","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.7150\/ijms.61973","volume":"18","author":"W-M Wang","year":"2021","unstructured":"Wang W-M, Li F, Jin H-Z (2021) Role of interferon regulatory factor-mediated signaling in psoriasis. Int J Med Sci 18:3794\u20133799","journal-title":"Int J Med Sci"},{"key":"1602_CR110","doi-asserted-by":"publisher","first-page":"2416837","DOI":"10.1155\/2020\/2416837","volume":"2020","author":"S Wen","year":"2020","unstructured":"Wen S, Zhang J, Yang B et al (2020) Role of resveratrol in regulating cutaneous functions. Evid Based Complement Alternat Med 2020:2416837","journal-title":"Evid Based Complement Alternat Med"},{"key":"1602_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090739","volume":"9","author":"Z Weng","year":"2014","unstructured":"Weng Z, Patel AB, Vasiadi M et al (2014) Luteolin inhibits human keratinocyte activation and decreases NF-\u03baB induction that is increased in psoriatic skin. PLoS\u00a0One 9:e90739","journal-title":"PLoS\u00a0One"},{"key":"1602_CR112","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/ncpendmet0323","volume":"2","author":"SF Witchel","year":"2006","unstructured":"Witchel SF, DeFranco DB (2006) Mechanisms of disease: regulation of glucocorticoid and receptor levels\u2013impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab 2:621\u2013631","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1602_CR113","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.det.2024.02.001","volume":"42","author":"AM Wride","year":"2024","unstructured":"Wride AM, Chen GF, Spaulding SL et al (2024) Biologics for psoriasis. Dermatol Clin 42:339\u2013355","journal-title":"Dermatol Clin"},{"key":"1602_CR114","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1346-8138.15913","volume":"48","author":"K Yamanaka","year":"2021","unstructured":"Yamanaka K, Yamamoto O, Honda T (2021) Pathophysiology of psoriasis: a review. J Dermatol 48:722\u2013731","journal-title":"J Dermatol"},{"key":"1602_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115124","volume":"292","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang Y, Chen X et al (2022) Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-\u03b1\/NF-\u03baB axis mediated transactivation of IL-17A and IL-33 in keratinocytes. J Ethnopharmacol 292:115124","journal-title":"J Ethnopharmacol"},{"key":"1602_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1139","volume":"9","author":"Y Ye","year":"2020","unstructured":"Ye Y, Gaugler B, Mohty M, Malard F (2020) Plasmacytoid dendritic cell biology and its role in immune-mediated diseases. Clin Transl Immunol 9:e1139","journal-title":"Clin Transl Immunol"},{"key":"1602_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109747","volume":"123","author":"X Yuan","year":"2020","unstructured":"Yuan X, Li N, Zhang M et al (2020) Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2\/STAT3 signal pathways. Biomed Pharmacother 123:109747","journal-title":"Biomed Pharmacother"},{"key":"1602_CR118","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","volume":"16","author":"S Zhang","year":"2016","unstructured":"Zhang S, Liu X, Mei L et al (2016) Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice. BMC Complement Altern Med 16:334","journal-title":"BMC Complement Altern Med"},{"key":"1602_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.903160","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wang J, Liu L et al (2022) Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms. Front Pharmacol 13:903160","journal-title":"Front Pharmacol"},{"key":"1602_CR120","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2015.12.040","volume":"772","author":"J Zhao","year":"2016","unstructured":"Zhao J, Di T, Wang Y et al (2016) Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion. Eur J Pharmacol 772:131\u2013143","journal-title":"Eur J Pharmacol"},{"key":"1602_CR121","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jid.2015.12.029","volume":"136","author":"F Zhou","year":"2016","unstructured":"Zhou F, Wang W, Shen C et al (2016) Epigenome-wide association analysis identified nine skin DNA methylation loci for psoriasis. J Investig Dermatol 136:779\u2013787","journal-title":"J Investig Dermatol"},{"key":"1602_CR122","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/medicines6010014","volume":"6","author":"X Zhou","year":"2019","unstructured":"Zhou X, Li C-G, Chang D, Bensoussan A (2019) Current status and major challenges to the safety and efficacy presented by Chinese herbal medicine. Medicines 6:14","journal-title":"Medicines"},{"key":"1602_CR123","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241266187","author":"T Zhou","year":"2024","unstructured":"Zhou T, Koussiouris J, Kim L, Vender R (2024) Management of guttate psoriasis: a systematic review. J Cutan Med Surg. https:\/\/doi.org\/10.1177\/12034754241266187","journal-title":"J Cutan Med Surg"},{"key":"1602_CR124","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5114\/ada.2021.108445","volume":"39","author":"B Zhu","year":"2022","unstructured":"Zhu B, Jing M, Yu Q et al (2022) Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy. Postep Dermatol Alergol 39:460\u2013471","journal-title":"Postep Dermatol Alergol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01602-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:40:17Z","timestamp":1740109217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1602"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01602-z","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}}]}}